Found: 43
Select item for more details and to access through your institution.
Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1068, doi. 10.1007/s10637-015-0271-1
- By:
- Publication type:
- Article
Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experience.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 664, doi. 10.1007/s10637-015-0231-9
- By:
- Publication type:
- Article
Modified-Irinotecan/Fluorouracil/ Levoleucovorin Therapy as Ambulatory Treatment for Metastatic Colorectal Cancer.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 4, p. 243, doi. 10.2165/11534470-000000000-00000
- By:
- Publication type:
- Article
Trajectory for the Regulatory Approval of a Combination of Pertuzumab Plus Trastuzumab for Pre-treated HER2-positive Metastatic Colorectal Cancer Using Real-world Data.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant.
- Published in:
- Immunogenetics, 2012, v. 64, n. 12, p. 869, doi. 10.1007/s00251-012-0646-9
- By:
- Publication type:
- Article
Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 7, p. 483, doi. 10.1007/s12325-010-0037-2
- By:
- Publication type:
- Article
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 2, p. 332, doi. 10.1007/s10120-016-0606-4
- By:
- Publication type:
- Article
Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 1, p. 183, doi. 10.1007/s10120-015-0471-6
- By:
- Publication type:
- Article
Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2015, v. 18, n. 4, p. 824, doi. 10.1007/s10120-014-0420-9
- By:
- Publication type:
- Article
Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 2, p. 383, doi. 10.1007/s10120-013-0264-8
- By:
- Publication type:
- Article
A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 1, p. 161, doi. 10.1007/s10120-013-0247-9
- By:
- Publication type:
- Article
Effect of RECIST revision on classification of target lesions and overall response in advanced gastric cancer patients.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 3, p. 324, doi. 10.1007/s10120-012-0187-9
- By:
- Publication type:
- Article
Future perspectives of chemotherapy for advanced gastric cancer.
- Published in:
- Gastric Cancer, 2013, p. 60, doi. 10.1007/s10120-008-0461-z
- By:
- Publication type:
- Article
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 21, p. 1667, doi. 10.1093/jnci/djt269
- By:
- Publication type:
- Article
Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2008, v. 13, n. 2, p. 144, doi. 10.1007/s10147-007-0737-z
- By:
- Publication type:
- Article
Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1216813
- By:
- Publication type:
- Article
Serum HER2 levels and HER2 status in tumor cells in advanced gastric cancer patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 1, p. 43, doi. 10.1093/jjco/hyu174
- By:
- Publication type:
- Article
Early Clinical Outcomes of Anal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy with 5-Fluorouracil Plus Mitomycin C in Japanese Patients: Experience at a Single Institution.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 9, p. 861, doi. 10.1093/jjco/hys093
- By:
- Publication type:
- Article
Multicenter Feasibility Study of Combination Therapy with Fluorouracil, Leucovorin and Paclitaxel (FLTAX) for Peritoneal Disseminated Gastric Cancer with Massive Ascites or Inadequate Oral Intake.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 9, p. 787, doi. 10.1093/jjco/hys111
- By:
- Publication type:
- Article
Induction Chemotherapy with Docetaxel, Cisplatin and S-1 Followed by Proton Beam Therapy Concurrent with Cisplatin in Patients with T4b Nasal and Sinonasal Malignancies.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 8, p. 691, doi. 10.1093/jjco/hys096
- By:
- Publication type:
- Article
Efficacy of Concurrent Chemoradiotherapy as a Palliative Treatment in Stage IVB Esophageal Cancer Patients with Dysphagia.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 8, p. 964, doi. 10.1093/jjco/hyr088
- By:
- Publication type:
- Article
Therapeutic Significance of a D-dimer Cut-off Level of >3 µg/ml in Colorectal Cancer Patients Treated with Standard Chemotherapy plus Bevacizumab.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 10, p. 933, doi. 10.1093/jjco/hyq058
- By:
- Publication type:
- Article
Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 4, p. 225, doi. 10.1093/jjco/hyp002
- By:
- Publication type:
- Article
Feasibility of Oxaliplatin and Infusional Fluorouracil/Leucovorin (FOLFOX4) for Japanese Patients with Unresectable Metastatic Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 6, p. 434, doi. 10.1093/jjco/hym068
- By:
- Publication type:
- Article
Phase II Study of Oral S-1 Plus Irinotecan in Patients with Advanced Colorectal Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302.
- Published in:
- Japanese Journal of Clinical Oncology, 2005, v. 35, n. 2, p. 88, doi. 10.1093/jjco/hyi025
- By:
- Publication type:
- Article
Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 6, p. 879, doi. 10.1093/jjco/hyaa276
- By:
- Publication type:
- Article
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1276-z
- By:
- Publication type:
- Article
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 409, doi. 10.1007/s00280-015-2810-z
- By:
- Publication type:
- Article
Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors.
- Published in:
- 2014
- By:
- Publication type:
- Report
Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese patients with advanced colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 643, doi. 10.1007/s00280-013-2240-8
- By:
- Publication type:
- Article
Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 227, doi. 10.1007/s00280-012-2000-1
- By:
- Publication type:
- Article
Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 3, p. 407, doi. 10.1007/s00280-012-1924-9
- By:
- Publication type:
- Article
Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1325, doi. 10.1007/s00280-011-1619-7
- By:
- Publication type:
- Article
Pharmacokinetics, safety, and efficacy of FOLFIRI plus bevacizumab in Japanese colorectal cancer patients with UGT1A1 gene polymorphisms.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 5, p. 495, doi. 10.1002/jcph.246
- By:
- Publication type:
- Article
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Future perspectives of chemotherapy for advanced gastric cancer.
- Published in:
- Gastric Cancer, 2009, v. 12, p. 60, doi. 10.1007/s10120-008-0461-z
- By:
- Publication type:
- Article
Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: A phase II study.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 5, p. 1228, doi. 10.1002/ijc.27320
- By:
- Publication type:
- Article
Guidelines for clinical evaluation of anti‐cancer drugs.
- Published in:
- Cancer Science, 2021, v. 112, n. 7, p. 2563, doi. 10.1111/cas.14967
- By:
- Publication type:
- Article
Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 9, p. 2875, doi. 10.1111/cas.14117
- By:
- Publication type:
- Article
Effect of food on the pharmacokinetics of TAS-102 and its efficacy and safety in patients with advanced solid tumors.
- Published in:
- Cancer Science, 2016, v. 107, n. 5, p. 659, doi. 10.1111/cas.12912
- By:
- Publication type:
- Article
Phase I/ II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/ III esophageal carcinoma ( JCOG 0604).
- Published in:
- Cancer Science, 2015, v. 106, n. 10, p. 1414, doi. 10.1111/cas.12764
- By:
- Publication type:
- Article